Loading dashboard...
Peptide Assistant
Online
AI can make mistakes. Verify important medical data.
Press Enter to send
G
Medical Engine
Guest Account
AI can make mistakes. Verify important medical data.
Press Enter to send
Medical Engine
Guest Account
Loading dashboard...
The convergence of focus and tranquility. Analyzing Neuroprotection vs Anxiolytic neural paths.
Both Semax and Selank are synthetic peptides developed by the Russian Academy of Sciences. They're derived from naturally occurring regulatory peptides (ACTH and tuftsin, respectively).
Semax: Derived from ACTH (adrenocorticotropic hormone). Promotes BDNF, dopamine, and neuroplasticity. Think "mental energy + focus."
Selank: Derived from tuftsin (immune peptide). Modulates GABA, serotonin, and enkephalins. Think "calm focus + mood stability."
No citations available
Semax: BDNF upregulation
Increases brain-derived neurotrophic factor → neurogenesis, learning, memory consolidation.
Selank: GABA modulation
Enhances GABAergic transmission → reduced anxiety, better stress response, mood stability.
Semax: "Clean stimulation"
Increased mental clarity, faster processing, verbal fluency. Like caffeine without jitters.
Selank: "Calm alertness"
Reduced social anxiety, improved mood, stress resilience. Like a mild anxiolytic without sedation.
Semax: Cognitive performance
High-stakes exams, demanding projects, public speaking, learning new skills.
Selank: Stress management
Social situations, general anxiety, burnout prevention, PTSD support (off-label).
Semax: Nasal spray (preferred)
2-3 sprays per nostril (300-600mcg). SubQ works but nasal = faster onset (15-20 min).
Selank: Nasal spray (standard)
2-3 sprays per nostril (300-600mcg). Nasal route is traditional in Russian clinical use.
Intranasal administration bypasses the blood-brain barrier (BBB) more effectively for neuropeptides.
Many users combine both for balanced cognitive enhancement:
Pro Tip: Don't dose both simultaneously (first time). Start with one, assess tolerance for 3-5 days, then add the second. The combination can be powerful.
Published: 2008
Note: Most research is Russian-language. Western clinical trials are limited. Both peptides are approved for medical use in Russia but remain "research chemicals" in the US.